China’s online juggernauts Alibaba Group Holding Ltd. and Tencent Holdings Ltd. are beating Silicon Valley in the race to build mobile-money systems in some of the world’s fastest-growing consumer markets.
NYS Entity Status
NYS Filing Date
AUGUST 08, 2013
NYS DOS ID#
NYS Entity Type
FOREIGN BUSINESS CORPORATION
2013 - CON-TECH SYSTEMS OF CANADA
2013 - CON-TECH SYSTEMS LTD.
Around the Web
- Alibaba and Tencent Set Fast Pace in Mobile-Payments Race
Friday Sep 22, 2017
- Alibaba Co-Founder Joseph Tsai Said to Buy Brooklyn Nets Stake
By MICHAEL J. de la MERCED and JOE DRAPE - Friday Oct 27, 2017
Mr. Tsai has agreed in principle to buy a 49 percent stake in the team, people briefed on the matter said, valuing the franchise at $2.3 billion.
- Citigroup, 21st Century Fox, Twitter: Prince’s Arrest Touches Many
By ALEXANDRA STEVENSON - Sunday Nov 5, 2017
Prince Alwaleed’s arrest is likely to reverberate across dozens of publicly listed companies that count him as a major investor.
- Our Guide to the Holiday Season’s Biggest Video Games and Consoles
By LAURA PARKER - Wednesday Nov 8, 2017
The industry is pushing out a diverse lineup of titles and promoting new consoles to compete for people’s wallets.
- FDA approves first digital ingestion tracking system med
Tuesday Nov 14, 2017
WASHINGTON (AP) — The Food and Drug Administration has approved the first drug in the United States with a digital ingestion tracking system, in an unprecedented move to ensure that patients with mental illness take the medicine prescribed for them.The drug Abilify MyCite was developed by Otsuka Pharmaceutical Co., Ltd. The drug Abilify was first approved by the FDA in 2002 to treat schizophrenia, and the ingestible sensor, made by Proteus Digital health, was approved for marketing in 2012. The FDA said in a statement Monday that the digitally enhanced medication "works by sending a message from the pill's sensor to a wearable patch.